Monitoring Early Clearance of Circulating Tumor DNA As an Effective Tool to Predict Clinical Benefits of Immune Checkpoint Inhibitors in Lung Cancer Patients: the Preliminary Results from Clinical Trial NCT04203095.
Journal of Clinical Oncology（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined